Based in Spain, Viralgen is a startup founded in 2017. Brouky records 2 investors associated with the company.
Viralgen is a contract development and manufacturing organization (CDMO) specializing in scalable AAV-based gene therapy manufacturing, offering end-to-end services from construct optimization through clinical and commercial production.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.